Communiqués IXICO plc

Actions

IXI

GB00BFXR4C20

Recherche biotechnologique et médicale

Marché Fermé - London S.E. 17:35:17 26/08/2026			Varia. 5j.	Varia. 1 janv.
7,750 ^GBX	0,00%		+3,33%	-34,04%

13/07	Le pétrole progresse, l'escalade avec l'Iran pèse sur le FTSE	AN
13/07	Ixico prend acte de l'arrêt de programmes sur la maladie de Huntington	AN

Communiqués

17/12	IXICO : AGM Notice 2026	PU
09/12	IXICO : ANNUAL RESULTS PRESENTATION (2025 Final Results Presentation FINAL v2)	PU
04/12	AI-Driven Recruitment for Alzheimer’s Disease Clinical Trials: A Pilot Analysis on the A4 Study Dataset	PU
01/12	IXICO : strengthens Scientific Advisory Board with two prominent global Alzheimer’s Disease and vascular experts	PU
17/11	IXICO : Global Phase 3 Clinical Trial Contract Win	PU
03/11	IXICO : CAPITAL MARKETS DAY PRESENTATION (Capital Markets Day 30 October 2025 FINAL 1)	PU
16/10/25	IXICO : CEO Bram Goorden on strong 2025 performance, 2026 priorities	PU
16/10/25	IXICO : CEO on strong 2025 performance, 2026 priorities	PU
16/10/25	IXICO : Trading update for the year ended 30 September 2025	PU
12/08/25	IXICO : Global clinical trial contract wins in Alzheimer’s Disease and Friedreich’s Ataxia	PU
22/07/25	IXICO : Strategic Partnership between IXICO and the Global Alzheimer’s Platform Foundation (GAP)	PU
06/06/25	IXICO : assists first FDA clearance of new Alzheimer’s Disease blood based diagnostic biomarker	PU
20/05/25	IXICO : Interim results for six months ending 31 March 2025	PU
16/04/25	IXICO : Half year Trading update FY2025	PU
11/03/25	Comparison of two natural history studies as part of the HD-IH consortium: a use case for historical external control group matching in clinical trials	PU
12/02/25	IXICO : Huntington’s Disease consortium further validates IXICO’s AI imaging platform	PU
16/12/24	IXICO : Commercial agreement with PETNET Solutions Inc, a Siemens Healthineers Company	PU
10/12/24	IXICO : US Client Clinical Trial Contract Win	PU
05/09/24	Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group - IOS Press	PU
05/08/24	IXICO : Appointment of CEO - Bram Goorden	PU
23/05/24	IXICO : to support on Global Alzheimer's Platform Foundation's Bio-Hermes 2 trial	PU
12/07/23	IXICO : Huntington’s Disease Image Harmonization Consortium secures new member and funding to complete large-scale analysis of brain changes using IXIQ.Ai	PU
03/04/23	IXICO : Deep-learning methods for enrichment of Alzheimer’s Disease clinical trials using MRI and PET	PU
16/12/22	IXICO : AGM 2023 – Notice	PU
12/12/22	IXICO : Application of fully automatic Hippocampal sub-field segmentation volumes to standard resolution T1 MR Imaging in Alzheimer’s disease	PU